Panam Biochem India Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 11-12-2024
- Paid Up Capital ₹ 1.96 M
as on 11-12-2024
- Company Age 17 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.86 Cr
as on 11-12-2024
- Satisfied Charges ₹ 5.00 M
as on 11-12-2024
- Revenue 64.86%
(FY 2022)
- Profit 97.54%
(FY 2022)
- Ebitda 127.82%
(FY 2022)
- Net Worth 27.24%
(FY 2022)
- Total Assets 19.54%
(FY 2022)
About Panam Biochem India
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.96 M.
The company currently has active open charges totaling ₹2.86 Cr. The company has closed loans amounting to ₹5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Pritesh Thakkar, Payal Thakkar, Vilas Thakkar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24119KA2007PTC042551
- Company No.
042551
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Apr 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Panam Biochem India?
Board Members(5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Pritesh Thakkar | Director | 19-Apr-2007 | Current |
Payal Thakkar | Director | 05-Nov-2008 | Current |
Vilas Thakkar | Director | 05-Nov-2008 | Current |
Jignesh Shah | Director | 02-Jun-2016 | Current |
Suryakant Devraj | Director | 01-Nov-2013 | Current |
Financial Performance of Panam Biochem India.
Panam Biochem India Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 64.86% increase. The company also saw a substantial improvement in profitability, with a 97.54% increase in profit. The company's net worth Soared by an impressive increase of 27.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Panam Biochem India?
In 2021, Panam Biochem India had a promoter holding of 26.02% and a public holding of 73.98%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Texnzymes India Private LimitedActive 7 years 11 months
Pritesh Thakkar, Jignesh Shah and 1 more are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 03 Jun 2023 | ₹1.75 Cr | Open |
Others Creation Date: 02 Aug 2022 | ₹1.11 Cr | Open |
Hdfc Bank Limited Creation Date: 05 Jan 2017 | ₹5.00 M | Satisfied |
How Many Employees Work at Panam Biochem India?
Panam Biochem India has a workforce of 19 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Panam Biochem India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Panam Biochem India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.